<?xml version="1.0" encoding="UTF-8"?>



<records>

  <record>
    <language>eng</language>
          <publisher>Oriental Scientific Publishing Company</publisher>
        <journalTitle>Biosciences Biotechnology Research Asia</journalTitle>
          <issn>0973-1245</issn>
            <publicationDate>2022-03-31</publicationDate>
    
        <volume>19</volume>
        <issue>1</issue>

 
    <startPage>37</startPage>
    <endPage>46</endPage>

	 
      <doi>10.13005/bbra/2966</doi>
        <publisherRecordId>40678</publisherRecordId>
    <documentType>article</documentType>
    <title language="eng">Escherichia coli Strains in Patients with Inflammatory Bowel Diseases; A review</title>

    <authors>
	 


      <author>
       <name>Hadba Al-Amrah </name>

 
		
	<affiliationId>1</affiliationId>
      </author>
    

	 


      <author>
       <name>Hanan Alotaibi</name>


		
	<affiliationId>1</affiliationId>

      </author>
    

	 


      <author>
       <name>Nemat Sadiq</name>

		
	<affiliationId>1</affiliationId>
      </author>
    

	


	


	
    </authors>
    
	    <affiliationsList>
	    
		
		<affiliationName affiliationId="1">Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah-21589, Saudi Arabia.</affiliationName>
    

		
		
		
		
		
	  </affiliationsList>






    <abstract language="eng"><p style="text-align: justify;">Gastrointestinal tract conditions, including inflammatory bowel diseases (IBDs) such as ulcerative colitis (UC) and Crohn’s disease, have been linked to adhesive invasive <em>Escherichia </em><em>c</em><em>oli</em> (AIEC) pathotypes, with comparable pathogenic properties, although the incidence of AIEC with UC and CD is generally undetermined. While a significant advance has been made in understanding the pathogenic processes of AIEC since it was first characterized a decade ago, the molecular basis that determines the phenotypic features of AIEC pathotypes is still unknown. This article reviews studies that examine the prevalence of <em>E.</em> <em>coli</em> in patients with IBD and discusses its pathophysiological role.</p></abstract>

    <fullTextUrl format="html">https://www.biotech-asia.org/vol19no1/escherichia-coli-strains-in-patients-with-inflammatory-bowel-diseases-a-review/</fullTextUrl>



      <keywords language="eng">
        <keyword>Adherent Invasive Escherichia Coli; Crohn’s Disease; Epidemiology; Inflammatory Bowel Disease; Pathogenesis</keyword>
      </keywords>

  </record>
</records>